Highbridge Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-52,173
| Closed | -$793K | – | 1132 |
|
|
2017
Q4 | $793K | Buy |
52,173
+6,068
| +13% | +$92.2K | 0.01% | 428 |
|
|
2017
Q3 | $826K | Buy |
+46,105
| New | +$826K | 0.01% | 452 |
|
|
2016
Q4 | – | Sell |
-59,854
| Closed | -$996K | – | 1321 |
|
|
2016
Q3 | $996K | Buy |
+59,854
| New | +$996K | 0.02% | 505 |
|
|
2016
Q1 | – | Sell |
-17,423
| Closed | -$162K | – | 1147 |
|
|
2015
Q4 | $162K | Buy |
+17,423
| New | +$162K | ﹤0.01% | 758 |
|
|
2015
Q2 | – | Sell |
-45,112
| Closed | -$420K | – | 1097 |
|
|
2015
Q1 | $420K | Buy |
45,112
+10,758
| +31% | +$100K | 0.01% | 606 |
|
|
2014
Q4 | $492K | Buy |
+34,354
| New | +$492K | 0.01% | 547 |
|
|
2013
Q4 | – | Sell |
-230,749
| Closed | -$2.53M | – | 968 |
|
|
2013
Q3 | $2.53M | Buy |
+230,749
| New | +$2.53M | 0.03% | 413 |
|